Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease–associated cachexia

Journal: Journal of Clinical Investigation

Published: 2020-06-16

DOI: 10.1172/jci138392

Affiliations: 4

Authors: 5

Go to article
Institutions Share
OHSU Papé Family Pediatric Research Institute, United States of America (USA) 0.60
Tensive Controls, Inc., United States of America (USA) 0.20
Dalton Cardiovascular Research Center, Mizzou, United States of America (USA) 0.10
Department of Medical Pharmacology and Physiology (MPP), Mizzou, United States of America (USA) 0.10

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER